ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.

Authors

Tejashree Joglekar, George Washington University
Jianqing Lin, George Washington University
Maho Shibata, George Washington University

Document Type

Editorial

Publication Date

2-3-2020

Journal

Expert Opinion on Therapeutic Targets

Inclusive Pages

1-2

DOI

10.1080/14728222.2020.1723080

Comments

Epub ahead of print

APA Citation

Joglekar, T., Lin, J., & Shibata, M. (2020). ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.. Expert Opinion on Therapeutic Targets, (). http://dx.doi.org/10.1080/14728222.2020.1723080

Peer Reviewed

1